Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis

Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis

We investigated the effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis for 3 and 5 years. Significant improvement found the decrease of the frequency of clinical exacerbations and delay the accumulation of physical disability during treatment period.

Saved in:

Bibliographic Details
Main Authors:	V. M. Alifirova, M. A. Titova, A. A. Vereschaka
Format:	Article
Language:	English
Published:	Siberian State Medical University (Tomsk) 2010-08-01
Series:	Бюллетень сибирской медицины
Subjects:	multiple sclerosis frequency of clinical exacerbations edss score
Online Access:	https://bulletin.ssmu.ru/jour/article/view/1618
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Prospective Study on 25 Hydroxyvitamin D Serum Levels in Patients with Relapsing-Remitting Multiple Sclerosis
by: Georgi Slavov, et al.
Published: (2014-11-01)

Fadiga na forma remitente recorrente da esclerose múltipla Fatigue in multiple sclerosis relapsing-remitting form
by: MARIA FERNANDA MENDES, et al.
Published: (2000-06-01)

Multiple sclerosis: report on 200 cases from Curitiba, Southern Brazil and comparison with other Brazilian series
by: Walter Oleschko Arruda, et al.
Published: (2001-06-01)

Características clínicas e epidemiológicas de 20 pacientes portadores de esclerose múltipla acompanhados em Cuiabá - Mato Grosso Clinical and epidemiologic characteristics of 20 patients with multiple sclerosis in Cuiabá - Mato Grosso, Brazil
by: Anderson Kuntz Grzesiuk
Published: (2006-09-01)

Pediatric-Onset Multiple Sclerosis (POMS) and Epilepsy: Exploring Etiological Complexity—Outcomes from a Single-Center Experience
by: Alice Denisa Dică, et al.
Published: (2025-05-01)

Adherence to therapeutic recommendation in relapsing-remitting multiple sclerosis patients
by: Justyna Chojdak-Łukasiewicz, et al.
Published: (2025-06-01)

Clinical and paraclinical features distinguish fatigue from depression-predominant phenotypes in multiple sclerosis
by: Yavor Yalachkov, et al.
Published: (2025-05-01)

Experience with the long-term use of interferons β in the treatment of relapsing-remitting multiple sclerosis. Case report
by: Taras O. Simaniv, et al.
Published: (2024-12-01)

Cognitive profile of patients with relapsing remitting multiple sclerosis
by: VIVIAN M. ANDRADE, et al.
Published: (1999-09-01)

Amygdala volume changes as a potential marker of multiple sclerosis progression: links to EDSS scores and PIRA
by: Aleksandra Pogoda-Wesołowska, et al.
Published: (2025-08-01)

Automated Quantitative Susceptibility and Morphometry MR Study: Feasibility and Interrelation Between Clinical Score, Lesion Load, Deep Grey Matter and Normal-Appearing White Matter in Multiple Sclerosis
by: Gibran Manasseh, et al.
Published: (2024-11-01)

Relationship between kappa light chain level and demyelinating lesion localization in secondary progressive multiple sclerosis
by: İbrahim Acır, et al.
Published: (2025-12-01)

EXPLORING THE ROLE OF GUT MICROBIOTA IN PATIENTS WITH MULTIPLE SCLEROSIS IN UKRAINE: A CROSS-SECTIONAL STUDY
by: Kateryna P. Potapova, et al.
Published: (2025-04-01)

Assessing female sexual dysfunction in patients with relapsing-remitting multiple sclerosis
by: Elisa Matias Vieira de Melo, et al.
Published: (2025-04-01)

Longitudinal analysis of verbal episodic memory in patients with relapsing-remitting multiple sclerosis
by: Izadora Nogueira Fonte Boa, et al.

Volumetric assessment of hypothalamus in relapsing–remitting multiple sclerosis
by: Sara Sameh AbdelRahman Abdallah, et al.
Published: (2025-07-01)

RESULTS OF AN OPEN-LABEL COMPARATIVE RANDOMIZED CLINICAL TRIAL OF AXOGLATIRAN® FS (F-SINTEZ, RUSSIA) EFFICIENCY AND SAFETY IN COMPARISON WITH COPAXONE®-TEVA (TEVA PHARMACEUTICAL INDUSTRIES LTD., ISRAEL) IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS
by: F. A. Khabirov, et al.
Published: (2017-01-01)

The condition of the cardiovascular system in patients with relapsing-remitting multiple sclerosis
by: O. A. Traktirskaya, et al.
Published: (2019-03-01)

Influence of treatment in multiple sclerosis dysability: an open, retrospective, non-randomized long-term analysis Influência do tratamento na incapacidade da esclerose múltipla: estudo aberto, retrospectivo e não randomizado em longo prazo
by: Lineu Cesar Werneck, et al.
Published: (2010-08-01)

Copaxone in therapy of remittent disseminated sclerosis patients
by: O. A. Kitcherova, et al.
Published: (2008-09-01)

Differentiation of relapsing-remitting and secondary progressive multiple sclerosis: a magnetic resonance spectroscopy study based on machine learning
by: Ziya EKŞİ, et al.

Corrigendum: Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis
by: Fernando Rodríguez-Jorge, et al.
Published: (2024-12-01)

Cost-Consequences of Cladribine Tablets for the Treatment of Highly Active Relapsing–Remitting Multiple Sclerosis in Italy
by: Barbara Polistena, et al.
Published: (2025-06-01)

The Relationship of 2D:4D Ratio and Hand Grip Strength to the Incidence of Multiple Sclerosis
by: Hamid Arazi, et al.
Published: (2018-07-01)

Motor symptoms and the quality of life of relapsing-remitting multiple sclerosis patients in a specialized center in South of Brazil
by: Francielle Fontana Jorge, et al.
Published: (2021-01-01)

Role of Diet and Supplementation with Omega-3 Polyunsaturated Fatty Acids for Managing Chronic Fatigue in Patients with Relapsing-Remitting Multiple Sclerosis
by: Nicholas Shepherd, et al.
Published: (2022-11-01)

Effects of Anti-CD20 Antibody Therapy on Immune Cell Dynamics in Relapsing-Remitting Multiple Sclerosis
by: Alice G. Willison, et al.
Published: (2025-04-01)

Mental health outcomes in pregnant women with relapsing-remitting multiple sclerosis: a longitudinal cohort study
by: Lena Kristina Pfeffer, et al.
Published: (2025-07-01)

Multiple sclerosis and pregnancy. Impact of multiple sclerosis disease-modifying therapy on the health of newborns
by: T. I. Yakushina
Published: (2021-02-01)

Epidemiological characteristics of multiple sclerosis in Tomsk Region and their dynamics for last 30 years
by: V. M. Alifirova, et al.
Published: (2012-06-01)

Positive correlation between functional disability, excessive daytime sleepiness, and fatigue in relapsing-remitting multiple sclerosis
by: Douglas Martins Braga, et al.
Published: (2016-06-01)

Reabilitação vestibular em pacientes com esclerose múltipla remitente-recorrente Vestibular rehabilitation in patients with relapsing- remitting multiple sclerosis
by: Karina Pavan, et al.
Published: (2007-06-01)

Comparative Effects of Vitamin D Supplementation on Oxidative Stress in Relapsing–Remitting Multiple Sclerosis
by: Martyna Lis, et al.
Published: (2024-12-01)

Evaluation of the Efficacy, Safety, and Adherence to Oral Drug Therapy in Patients with Relapsing–Remitting Multiple Sclerosis
by: Paulius Sėdžius, et al.
Published: (2025-04-01)

AI-driven MRI analysis reveals brain atrophy patterns in benign relapsing-remitting multiple sclerosis
by: M. Niiranen, et al.
Published: (2025-05-01)

Characteristics and correlations of sleep disorders in patients with relapsing–remitting multiple sclerosis in China: a cross-sectional study
by: Rongrong Wang, et al.
Published: (2025-07-01)

Dawson’s finger radiological presentation of relapsing remitting multiple sclerosis in a young female: a case report and review of the literature
by: Hadeel Al-Husban, et al.
Published: (2025-04-01)

The influence of personality traits and coping strategies on the quality of life of patients with relapsing-remitting type of multiple sclerosis
by: Krstić Dragan, et al.
Published: (2021-01-01)

Gadolinium deposition in the brain of patients with relapsing-remitting multiple sclerosis after 10 years of follow-up
by: Kostić Dejan, et al.
Published: (2023-01-01)

Assessment of the impact of reconstitution therapies—cladribine tablets and alemtuzumab—on the atrophy progression among patients with relapse-remitting multiple sclerosis
by: Aleksandra Pogoda-Wesołowska, et al.
Published: (2025-02-01)